Smoke-Free Home Program for Smoking Cessation
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a program designed to help residents of supportive housing make their homes smoke-free. Researchers aim to determine if this program can reduce smoking-related health issues. The program includes personal counseling for residents ("Resident Counselling") and training for staff ("Staff Training"). Individuals who smoke and live in supportive housing in the San Francisco Bay Area may be suitable participants, particularly if they smoke at home. As an unphased trial, this study provides a unique opportunity to contribute to research that could enhance health outcomes for supportive housing residents.
Do I have to stop taking my current medications for this trial?
The trial protocol does not specify whether you need to stop taking your current medications. It focuses on smoking cessation and smoke-free homes, so it's best to consult with the trial coordinators for specific guidance.
What prior data suggests that this smoke-free home intervention is safe for residents?
Research shows that talking with residents and training staff effectively promote smoke-free homes. Studies have found that discussing quitting smoking and the benefits of a smoke-free home often helps people smoke less and poses no harm. Many high-quality studies support this approach.
For staff training, research also confirms its safety. Staff learn about tobacco use and how to assist residents in quitting smoking. This training has been used in other programs to create smoke-free homes without negative effects.
Overall, both methods are safe and have proven effective in previous studies.12345Why are researchers excited about this trial?
Researchers are excited about the Smoke-Free Home Program for smoking cessation because it takes a unique approach by integrating personalized counseling and staff training specifically for residents in permanent supportive housing. Unlike standard care options that often lack proactive smoke-free home initiatives, this program provides a step-by-step guide to help residents voluntarily adopt a smoke-free home. It also addresses the effects of secondhand and third-hand smoke on pets and children and explores personal costs related to tobacco use, which are rarely covered in typical smoking cessation programs. This comprehensive and tailored method could potentially offer more effective support for individuals looking to create a healthier living environment.
What evidence suggests that this trial's treatments could be effective for smoking cessation?
Research has shown that counseling, which participants in this trial may receive as part of the Smoke-Free Home Program, can significantly increase the number of people choosing to make their homes smoke-free. One study found that 30.3% of people adopted smoke-free homes with counseling, compared to only 12% without it. Similar programs have also helped people smoke less and attempt to quit more often.
For staff training, another component of this trial, research indicates it can effectively promote smoke-free homes in low-income areas. In several studies, 38%–63% of households maintained smoke-free homes after six months. This suggests that both counseling and staff training, as tested in this trial, effectively create smoke-free homes.24678Who Is on the Research Team?
Maya Vijayaraghavan, MD
Principal Investigator
University of California, San Francisco
Are You a Good Fit for This Trial?
This trial is for English-speaking adults who currently smoke in their homes, have smoked at least 100 cigarettes in their lifetime, and are living in permanent supportive housing. They should expect to stay there for at least a year and be able to follow the study's procedures.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Recruitment and Enrollment
Participants are recruited and enrolled into the study across multiple housing sites
Intervention
Participants receive a one-hour, one-on-one counseling session on adopting a smoke-free home
Follow-up
Participants are monitored for voluntary adoption of smoke-free homes and abstinence
Crossover Intervention for Wait-list Control
Wait-list control participants receive the smoke-free home intervention after the initial intervention group completes follow-up
What Are the Treatments Tested in This Trial?
Interventions
- Resident counselling
- Staff Training
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, San Francisco
Lead Sponsor
National Cancer Institute (NCI)
Collaborator